Abstract

Myada Ahmed Musa Haroon51864* and Amira Altom Fawzi Osman51865

Background: Hepatitis E Virus (HEV) infection is a newly recognized serious threat to global public health and Africa is suspected to be among the most severely affected regions in the world.

Objective: This study aimed to detect the frequency of anti-hepatitis E IgM, among elevated liver enzyme patients.

Methods: The current study is descriptive cross-sectional study carried out between April to august 2016, Ninety Patients with high liver enzyme ALT and AST and non B non C hepatitis attended Ibn senaa hospital Khartoum north, Omdurman teaching hospital and bahri teaching hospital bahri north, sedan were collected and tested by using (ELISA) kit

Results: show that Out of the 90 samples tested in order to evaluate the effect of age on HEV seropositivity, there was a significant difference (p<0.05) between HEV seropositivity and age group.

Conclusion: Study demonstrates the high prevalence rate of HEV seropositivity among non-hepatitis patients with high level enzyme ALT, AST. This will raise the potential risk of HEV infection by blood transfusion and may be the source of the outbreak.